DCM Shriram Limited commissions full capacity of Epichlorohydrin Plant
DCM Shriram · Diversified
Key highlights
- Additional 17,000 TPA capacity of ECH plant commissioned on 1st April 2026 at 4:00 pm
- Total ECH plant capacity now 52,000 TPA at Chemical complex in Jhagadia, Bharuch Dist., Gujarat
- Earlier communication on partial commissioning was dated 14th October 2025
Why it's rated notable: The filing states no amount, and the commissioning of the remaining 17,000 TPA brings the ECH plant to its full 52,000 TPA capacity, so the level is kept at medium.
Original filing
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Commissioning Of Epichlorohydrin (ECH) Plant
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from DCM Shriram
- Capex / expansionNotableDCM Shriram Limited announces full commissioning of 68 MW renewable power project
- Acquisition / mergerNotable· Adverse for the businessDCM Shriram Ltd announces Q2 FY27 financials, interim dividend, and JV equity investment
- Dividend / buyback / bonusMajor development· Adverse for the businessDCM Shriram Ltd approves Q2 FY 2027 results, interim dividend and JV equity infusion
- Dividend / buyback / bonusMajor development· Adverse for the businessDCM Shriram Ltd reports Sept 2026 quarter results and declares ₹4.00 interim dividend
- Dividend / buyback / bonusMajor development· Adverse for the businessDCM Shriram Ltd reports 22% revenue growth in Q2 FY27 to ₹3,977 crore
Other capex / expansion filings this fortnight
- Maharaja & Speedex India Limited raises manufacturing capacity to 72 lakh units/year
- Elin Electronics Q2 FY27 earnings report with 10% revenue growth and margin update
- HOAC Foods India Limited H1 FY27 Earnings Call Transcript dated November 5, 2026
- Gujarat State Fertilizers & Chemicals Limited Q2 FY27 Earnings Call Highlights
- Supriya Lifescience H1 revenue up 14.8% to ₹396.04 crore; Q2 profit falls
- V-MARC India Ltd announces Q2 & H1 FY27 unaudited financial results and review report
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.